glp-1 for crohn's Agonists and Disease: Risks and Management ulcerative colitis glp 1 New

GLP-1 medications prescribed to treat type 2 diabetes may affect a persons sense of smell and taste, according to a new study

Our legal team works directly with clients to review medical records, evaluate potential claims, and build strong cases against drug manufacturers, pharmacies, or negligent healthcare providers

This regulatory shift has implications for availability and pricing

JAMAs Ophthalmology published findings that people taking semaglutide drugs, like Ozempic and Wegovy, may suffer vision loss

Patients deserve that clarity before a wellness trend hardens into an assumption

Ozempic/Wegovy (semaglutide) is not a controlled substance no DEA registration needed, no PDMP checks required, generally fewer regulatory restrictions